Practice Patterns in the Diagnosis and Treatment of Polycythemia Vera in the Post–JAK2V617F Discovery Era

Journal of the National Comprehensive Cancer Network : JNCCN - United States
doi 10.6004/jnccn.2016.0133
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Harborside Press, LLC

Related search

Alox5 Blockade Eradicates JAK2V617F -Induced Polycythemia Vera in Mice

Cancer Research
Cancer ResearchOncology
2016English

Erlotinib Effectively Inhibits JAK2V617F Activity and Polycythemia Vera Cell Growth

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Cytoreductive Treatment Patterns Among US Veterans With Polycythemia Vera

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Ropeginterferon Alpha-2b Targets JAK2V617F-positive Polycythemia Vera Cells in Vitro and in Vivo

Blood Cancer Journal
OncologyHematology
2018English

Recombinant Interferon Alpha in the Treatment of Polycythemia Vera [Letter; Comment]

Blood
BiochemistryImmunologyCell BiologyHematology
1991English

Polycythemia Vera

Journal of Clinical Investigation
Medicine
1980English

Clonal Analyses Reveal Associations of JAK2V617F Homozygosity With Hematologic Features, Age and Gender in Polycythemia Vera and Essential Thrombocythemia

Haematologica
Hematology
2013English

Updates in the Management of Polycythemia Vera and Essential Thrombocythemia

Therapeutic Advances in Hematology
Hematology
2019English

Erythropoietin Receptors in Polycythemia Vera.

Journal of Clinical Investigation
Medicine
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy